Загрузка...
Bedaquiline versus placebo for management of multiple drug-resistant tuberculosis: A systematic review
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is associated with significant morbidity and mortality. Bedaquiline is the first drug approved for treating MDR-TB. OBJECTIVES: We performed a systematic review and meta-analysis to summarize the totality of all available evidence on the efficacy...
Сохранить в:
| Опубликовано в: : | Indian J Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825437/ https://ncbi.nlm.nih.gov/pubmed/27127322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.178839 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|